Dr. Panchajanya Paul, MD

Dr. Paul practices at Ridgeview Institute Smyrna in Smyrna, Georgia, part of US HealthVest.

Dr. Paul's NPI, 1356664007, was assigned on March 9, 2010. Dr. Paul graduated from Kasturba Medical College Manipal in 2007. Dr. Paul holds Georgia license 069419.

Dr. Paul's primary practice is Ridgeview Institute Smyrna, at 3995 S Cobb Drive, SE, Smyrna, GA 30080 in Cobb County. The practice phone is (770) 434-4567.

Dr. Paul's primary practice is Ridgeview Institute Smyrna in Smyrna, Georgia, part of US HealthVest. The medical group on file is Via Linda Behavioral Hospital. Dmand AI also links Dr. Paul to 2 more medical groups, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paul practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Paul's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Paul is board certified in child & adolescent psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Paul's licenses on file in 4 states: Georgia, Arizona, Florida and Ohio.

Dmand AI lists ADHD, anxiety, bipolar disorder, depression, insomnia, psychoses, schizophrenia and substance abuse among the conditions Dr. Paul treats.

CMS data shows 559 Medicare services from Dr. Paul across 8 procedure codes in 2024, for 51 Medicare patients. Medicare paid $42,043 for them.

CMS counts 51 Medicare patients who saw Dr. Paul in 2024. The largest group is under 65, with 25 patients. 75% of them have anxiety, and 75% have depression. 41% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Paul's median patient age at 38, with 57% women.

In 2024, Dr. Paul wrote 1,829 Medicare Part D claims for 108 patients. 98% of them were for generic drugs. CMS names the drug for 1,575 of them, across 37 drugs with 11 or more claims each, at $23,214 in total drug cost. In 2023, CMS named 908 claims across 32 drugs.

Dr. Paul accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paul as offering telehealth.

Dmand AI links 3 papers to Dr. Paul. Dr. Paul has published most often in J Child Adolesc Psychopharmacol. Dr. Paul's most frequent co-authors are Barbara Jane Coffey, MD and Ronald A. Mcginnis, MD.

CMS Open Payments shows 85 general payments to Dr. Paul from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $8,674.

Dr. Paul graduated from Kasturba Medical College Manipal in 2007.

Dr. Paul is in network with 12 carriers, including Aetna, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.